Company profile for RS Research

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

RS Research is a clinical-stage biotech start-up focused on developing smart nanomedicines for targeted chemotherapy. Combining scientific innovation with industrial expertise, the company has created Sagitta??a proprietary drug delivery platform that enables the design of targeted therapies with improved therapeutic index. With a mission to offer ?a Cure With a Smile,? RS Research is advancing its oncology portfolio while unl...
RS Research is a clinical-stage biotech start-up focused on developing smart nanomedicines for targeted chemotherapy. Combining scientific innovation with industrial expertise, the company has created Sagitta??a proprietary drug delivery platform that enables the design of targeted therapies with improved therapeutic index. With a mission to offer ?a Cure With a Smile,? RS Research is advancing its oncology portfolio while unlocking strong co-development opportunities across multiple indications.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Turkey
Address
Address
Teknopark Istanbul, Sanayi Mah. Teknopark Blv., No:1/2A-401 34912, Pendik / Is...
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

AMWC Asia-TDAC

AMWC Asia-TDAC

Not Confirmed

envelop Contact Supplier

AMWC Asia-TDAC

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty